Malawi study tracks Women's HIV prevention choices to boost PrEP success

NCT ID NCT07579754

First seen May 13, 2026 · Last updated May 23, 2026 · Updated 4 times

Summary

This study looks at how women in Blantyre, Malawi choose and use HIV prevention pills (oral PrEP) or shots (injectable PrEP). Researchers will follow 384 women to see why some stop PrEP and how tracing them can help re-engage them in care. The goal is to improve HIV prevention programs for women at risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORAL PRE-EXPOSURE PROPHYLAXIS (PREP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins Research Project Malawi

    Blantyre, Malawi

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.